CUMBERLAND PHARMACEUTICALS INC reports

Company location: Nashville,, TN
Fiscal year end: 31 December

CUMBERLAND PHARMACEUTICALS INC has filed 1,032 SEC EDGAR filings since 02 May 2002

Filter by type:
10-K
10-Q
8-K
SC13G

SEC filing history

Showing 176-200 of 959 matching filings.

Per page

25

Current page

8

DEL AM File 333-276052

DEL AM

Filing date: 15 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-276052

S-3

Filing date: 14 Dec 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Dec 2023
Reporting date: 27 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Dec 2023
Reporting date: 01 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Dec 2023
Reporting date: 01 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 06 Dec 2023
Reporting date: 01 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

PRIMARY DOCUMENT

Filing date: 06 Dec 2023
Reporting date: 16 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Nov 2023
Reporting date: 01 Nov 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-33637

10-Q

Filing date: 13 Nov 2023
Reporting date: 30 Sep 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-33637

8-K

Filing date: 07 Nov 2023
Reporting date: 07 Nov 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Nov 2023
Reporting date: 02 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Nov 2023
Reporting date: 02 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Nov 2023
Reporting date: 02 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Nov 2023
Reporting date: 17 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 17 Oct 2023
Reporting date: 02 Oct 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-33637

8-K

Filing date: 13 Oct 2023
Reporting date: 13 Oct 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Oct 2023
Reporting date: 05 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Oct 2023
Reporting date: 05 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Oct 2023
Reporting date: 18 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 03 Oct 2023
Reporting date: 05 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 19 Sep 2023
Reporting date: 05 Sep 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 08 Sep 2023
Reporting date: 16 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 08 Sep 2023
Reporting date: 16 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 08 Sep 2023
Reporting date: 16 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 08 Sep 2023
Reporting date: 16 Aug 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .